CAHIC(SH:600195) Qian Zhan Wang·2025-05-04 07:42Core Insights - The global animal vaccine industry has seen continuous growth, with a market size exceeding $13.5 billion in 2023 and a compound annual growth rate (CAGR) of 10.10% over the past five years, indicating increasing emphasis on disease prevention in animals and food safety [1][15] - The quality of animal vaccine products is directly linked to the safety of livestock products and, consequently, public food safety, leading to significant national attention and planning for the industry [1] - Local governments are actively promoting the development of animal vaccine enterprises, focusing on attracting advanced technologies and management practices to enhance local industry standards [1] Industry Overview - The animal vaccine market is projected to reach $3.8 billion by 2029, driven by the commercialization of vaccines for diseases like African swine fever and increasing pet vaccination awareness among residents [15] - In 2023, North America accounted for approximately 45% of the global animal vaccine market, making it the largest regional market [9] Key Players - Qingdao Yebio Bioengineering Co., Ltd. is a leading player in the domestic animal vaccine industry, with 87 vaccine products, the highest in the market, and an annual R&D investment of about 9% of its sales [7] - Other notable companies in the industry include China Animal Husbandry Industry Co., Ltd. and Tianjin Reap Bio-Technology Co., Ltd., both of which have significant revenue from animal vaccine operations [7][2] Regulatory and Developmental Support - The Chinese government has included animal vaccines in its "14th Five-Year Plan," highlighting the importance of the industry and encouraging local governments to support enterprise development [1] - The industry is characterized by a focus on innovation, with many companies establishing national key laboratories and innovation platforms to advance vaccine research and development [7]